|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2002-12-30
|
|
pubmed:abstractText |
A prospective Phase II trial was carried out to evaluate the effectiveness of erythropoietin in improving or maintaining performance status as determined by the Karnofsky performance status (KPS) score and hemoglobin (Hb) levels in lung cancer patients treated with concurrent chemoradiation (CH-RT).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
0360-3016
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
1
|
|
pubmed:volume |
55
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
116-24
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:12504043-Adult,
pubmed-meshheading:12504043-Aged,
pubmed-meshheading:12504043-Combined Modality Therapy,
pubmed-meshheading:12504043-Erythropoietin,
pubmed-meshheading:12504043-Female,
pubmed-meshheading:12504043-Hemoglobins,
pubmed-meshheading:12504043-Humans,
pubmed-meshheading:12504043-Lung Neoplasms,
pubmed-meshheading:12504043-Male,
pubmed-meshheading:12504043-Middle Aged,
pubmed-meshheading:12504043-Prospective Studies,
pubmed-meshheading:12504043-Quality of Life,
pubmed-meshheading:12504043-Recombinant Proteins,
pubmed-meshheading:12504043-Survival Rate
|
|
pubmed:year |
2003
|
|
pubmed:articleTitle |
Improvement in performance status after erythropoietin treatment in lung cancer patients undergoing concurrent chemoradiotherapy.
|
|
pubmed:affiliation |
Department of Radiation Oncology, Hospital Clinic, Barcelona, Spain. fcasas@clinic.ub.es
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Clinical Trial, Phase II
|
